Literature DB >> 16959927

Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15).

Alejandro Interian1, Lesley A Allen, Michael A Gara, Javier I Escobar, Angélica M Díaz-Martínez.   

Abstract

The authors examined the reliability and validity of the PHQ-15, a measure of current somatic complaints. An index of medically unexplained symptoms was used as a key criterion. Data were utilized from medical outpatients enrolled in a treatment study for moderate-to-severe somatization (N=172). Approximately 68% of the sample was Hispanic. Results showed that the PHQ-15 was moderately related to a history of medically unexplained symptoms among non-Hispanic participants. Results indicated ethnic differences on the validity profile of the PHQ-15 showing that the criterion variables were less predictive of the PHQ-15 among Hispanics than among non-Hispanics. Also, among the Hispanic group, the PHQ-15 was less related to medically unexplained symptoms and more to psychiatric distress. General support was provided for using the PHQ-15 with clinical samples composed of non-Hispanics. Also, the PHQ-15 appears to measure medically unexplained symptoms, psychiatric distress, and physical functioning. Further study is recommended to better evaluate ethnic variations and other types of validity for the PHQ-15.

Entities:  

Mesh:

Year:  2006        PMID: 16959927     DOI: 10.1176/appi.psy.47.5.392

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  23 in total

1.  Subjective versus objective: an exploratory analysis of latino primary care patients with self-perceived depression who do not fulfill primary care evaluation of mental disorders patient health questionnaire criteria for depression.

Authors:  Susan Caplan; Jennifer Alvidrez; Manuel Paris; Javier I Escobar; Jane K Dixon; Mayur M Desai; Robin Whittemore; Lawrence D Scahill
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Nuevo Amanecer: results of a randomized controlled trial of a community-based, peer-delivered stress management intervention to improve quality of life in Latinas with breast cancer.

Authors:  Anna María Nápoles; Carmen Ortíz; Jasmine Santoyo-Olsson; Anita L Stewart; Steven Gregorich; Howard E Lee; Ysabel Durón; Peggy McGuire; Judith Luce
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

3.  Ethnic differences in somatic symptom reporting in children with asthma and their parents.

Authors:  Juan C Vasquez; Gregory K Fritz; Sheryl J Kopel; Ronald Seifer; Elizabeth L McQuaid; Glorisa Canino
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-08       Impact factor: 8.829

4.  Bidirectional associations of insomnia symptoms with somatic complaints and posttraumatic stress disorder in child and adolescent earthquake survivors: a longitudinal study.

Authors:  Ye Zhang; Jun Zhang; Rong Ren; Xiangdong Tang
Journal:  Sleep Breath       Date:  2019-11-08       Impact factor: 2.816

5.  Screening for Behavioral Health Conditions in Primary Care Settings: A Systematic Review of the Literature.

Authors:  Norah Mulvaney-Day; Tina Marshall; Kathryn Downey Piscopo; Neil Korsen; Sean Lynch; Lucy H Karnell; Garrett E Moran; Allen S Daniels; Sushmita Shoma Ghose
Journal:  J Gen Intern Med       Date:  2017-09-25       Impact factor: 5.128

6.  A clinician-administered severity rating scale for illness anxiety: development, reliability, and validity of the H-YBOCS-M.

Authors:  Natalia A Skritskaya; Amanda R Carson-Wong; James R Moeller; Sa Shen; Arthur J Barsky; Brian A Fallon
Journal:  Depress Anxiety       Date:  2012-04-13       Impact factor: 6.505

7.  Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.

Authors:  Mark D Sullivan; Judith A Turner; Cory DiLodovico; Angela D'Appollonio; Kari Stephens; Ya-Fen Chan
Journal:  J Pain       Date:  2016-11-28       Impact factor: 5.820

8.  Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study.

Authors:  Y S Shim; C-U Pae; K J Cho; S W Kim; J C Kim; J S Koh
Journal:  Int J Impot Res       Date:  2013-11-28       Impact factor: 2.896

9.  Quality of life among free clinic patients associated with somatic symptoms, depression, and perceived neighborhood environment.

Authors:  Akiko Kamimura; Nancy Christensen; Jamie A Prevedel; Jennifer Tabler; Brian J Hamilton; Jeanie Ashby; Justine J Reel
Journal:  J Community Health       Date:  2014-06

10.  Severe MUPS in a sick-listed population: a cross-sectional study on prevalence, recognition, psychiatric co-morbidity and impairment.

Authors:  Rob Hoedeman; Boudien Krol; Nettie Blankenstein; Petra C Koopmans; Johan W Groothoff
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.